247 related articles for article (PubMed ID: 26376646)
1. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
[TBL] [Abstract][Full Text] [Related]
2. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
3. Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations.
Tsongalis GJ; Peterson JD; de Abreu FB; Tunkey CD; Gallagher TL; Strausbaugh LD; Wells WA; Amos CI
Clin Chem Lab Med; 2014 May; 52(5):707-14. PubMed ID: 24334431
[TBL] [Abstract][Full Text] [Related]
4. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
6. Integrative molecular profiling of routine clinical prostate cancer specimens.
Grasso CS; Cani AK; Hovelson DH; Quist MJ; Douville NJ; Yadati V; Amin AM; Nelson PS; Betz BL; Liu CJ; Knudsen KE; Cooney KA; Feng FY; McDaniel AS; Tomlins SA
Ann Oncol; 2015 Jun; 26(6):1110-1118. PubMed ID: 25735316
[TBL] [Abstract][Full Text] [Related]
7. BRCA1/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients.
Lee A; Kang J; Lee H; Lee YS; Choi YJ; Lee KH; Nistala GJ; Scafe CR; Choi J; Yoo J; Han M D E; Kim Y; Kim M
Pathol Res Pract; 2019 Nov; 215(11):152595. PubMed ID: 31570282
[TBL] [Abstract][Full Text] [Related]
8. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.
Bhagwate AV; Liu Y; Winham SJ; McDonough SJ; Stallings-Mann ML; Heinzen EP; Davila JI; Vierkant RA; Hoskin TL; Frost M; Carter JM; Radisky DC; Cunningham JM; Degnim AC; Wang C
BMC Genomics; 2019 Sep; 20(1):689. PubMed ID: 31477010
[TBL] [Abstract][Full Text] [Related]
10. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
11. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
[TBL] [Abstract][Full Text] [Related]
12. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
[TBL] [Abstract][Full Text] [Related]
13. Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.
Ivanov M; Laktionov K; Breder V; Chernenko P; Novikova E; Telysheva E; Musienko S; Baranova A; Mileyko V
J Transl Med; 2017 Jan; 15(1):22. PubMed ID: 28137276
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
[TBL] [Abstract][Full Text] [Related]
15. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
Zakrzewski F; Gieldon L; Rump A; Seifert M; Grützmann K; Krüger A; Loos S; Zeugner S; Hackmann K; Porrmann J; Wagner J; Kast K; Wimberger P; Baretton G; Schröck E; Aust D; Klink B
BMC Cancer; 2019 Apr; 19(1):396. PubMed ID: 31029168
[TBL] [Abstract][Full Text] [Related]
16. Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
Bonnet E; Moutet ML; Baulard C; Bacq-Daian D; Sandron F; Mesrob L; Fin B; Delépine M; Palomares MA; Jubin C; Blanché H; Meyer V; Boland A; Olaso R; Deleuze JF
PLoS One; 2018; 13(4):e0195471. PubMed ID: 29621323
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
[TBL] [Abstract][Full Text] [Related]
18. Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
Zhang L; Chen L; Sah S; Latham GJ; Patel R; Song Q; Koeppen H; Tam R; Schleifman E; Mashhedi H; Chalasani S; Fu L; Sumiyoshi T; Raja R; Forrest W; Hampton GM; Lackner MR; Hegde P; Jia S
Oncologist; 2014 Apr; 19(4):336-43. PubMed ID: 24664487
[TBL] [Abstract][Full Text] [Related]
19. Using postmortem formalin fixed paraffin-embedded tissues for molecular testing of sudden cardiac death: A cautionary tale of utility and limitations.
Lin Y; Gryazeva T; Wang D; Zhou B; Um SY; Eng LS; Ruiter K; Rojas L; Williams N; Sampson BA; Tang Y
Forensic Sci Int; 2020 Mar; 308():110177. PubMed ID: 32155531
[TBL] [Abstract][Full Text] [Related]
20. Effective quality management practices in routine clinical next-generation sequencing.
de Abreu FB; Peterson JD; Amos CI; Wells WA; Tsongalis GJ
Clin Chem Lab Med; 2016 May; 54(5):761-71. PubMed ID: 26872315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]